P3 Health Partners Inc. PIIIW

FY2024 · ended Dec 31, 2025 · Revenue $1.46B, -2.8% YoY · Filed Mar 26, 2026

P3 Health Partners Inc. (PIII) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2024, which ended Dec 31, 2025, it reported revenue of $1.5 billion and a net loss of $147.9 million. As of Jun 30, 2026 it held $21.3 million in cash and investments and $130.7 million in total debt.

Revenue
$1.46B
-2.8% vs prior year
Net income
$-147.95M
-8.9% vs prior year
Operating cash flow
$-91.24M
+17.2% vs prior year
Free cash flow
$-110.13M
-41.5% vs prior year
EPS
$-45.26
+16.3% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$-109.42M
as of Jun 30, 2026
Operating margin
-18.5%
FY 2024

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
PIII (Nasdaq), PIIIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1832511
Former names
Foresight Acquisition Corp. (until Dec 3, 2021)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2024
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 2, 2021
Revenue
$1.5B
$1.5B
$1.3B
$1.0B
$578.6M
Operating income
-$270.3M
-$320.7M
-$167.9M
-$1.6B
-$129.1M
Net income
-$147.9M
-$135.8M
-$57.8M
-$270.1M
-$146.4M
Diluted EPS
-$45.26
-$54.06
-$0.63
-$6.50
—
Operating cash flow
-$91.2M
-$110.1M
-$76.0M
-$126.0M
-$51.1M
Free cash flow
—
-$110.1M
-$77.9M
-$128.3M
-$54.4M
Total assets
$656.6M
$783.4M
$861.0M
$876.6M
—
Total liabilities
$796.9M
$633.9M
$427.3M
$353.9M
—
Stockholders' equity
-$155.2M
$75.9M
$142.1M
—
—
Cash and investments
$25.0M
$38.8M
$36.3M
$17.5M
—
Total debt
$287.3M
$197.9M
$124.7M
$107.2M
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Sep 11, 2026 Sep 4, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Material agreement
Jul 6, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 9, 2026
8-K Current report
Listing notice
May 26, 2026 May 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.